Novo Nordisk raises full-year guidance again as US sales of Wegovy, Ozempic fly | Reuters
Novo Nordisk shares fall on Wegovy news despite outlook lift | Reuters
Novo Nordisk do rekordnih prihodkov ob pomanjkanju zdravila za hujšanje Wegovy - Forbes Slovenija
Flagship drug makes Novo Nordisk Europe's most valuable company, dethroning LVMH | Euronews
NOVOPEN 5 INSULIN PEN BY NOVO NORDISK A/S - Vandtårnsvej 108, 2860 Søborg, Denmark
Novo Nordisk - Wikipedia
Novo Nordisk raises profit guidance as weight-loss drug sales boom
Novo Nordisk - Future-Fit Business
Novo Nordisk comments on role of off-label use in Ozempic shortfall
Novo Nordisk foundation to place more grants outside Denmark | Reuters
Novo Nordisk, Flagship's forward-thinking partnership aims to treat cardiometabolic, rare diseases | Fierce Biotech
Novo Nordisk Pharmatech A/S | LinkedIn
Novo Nordisk stock hits record on new weight loss drug trial
Signal: Novo Nordisk market cap higher than Danish GDP due to obesity drugs - Pharmaceutical Technology
Novo Nordisk market cap surpasses Tesla on new obesity pill trial data
Novo Nordisk logo
Novo Nordisk to Sell Discount Insulin After Criticism Over Price - Bloomberg
Kontaktirajte nas
Team Novo Nordisk and Novo Nordisk confirm three-year renewal of historic partnership
Novo Nordisk Gets 2023 Profit Beat Fueled by Ozempic, Wegovy Sales Spike | BioSpace
Novo Nordisk - IFPMA
Ozempic's Surging Popularity Has Novo Nordisk (NVO) Struggling to Meet Demand - Bloomberg
Novo Nordisk
